Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalised Medicine in Prediabetes (PREDICT)
NCT03558867Completed
- Sponsor
- Garvan Institute of Medical Research
- Start
- Jun 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of liquid metformin (Aspargo Labs) in prediabetes and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Garvan Institute of Medical Research. Primary endpoint: Glycated Haemoglobin at 6 months. Started Jun 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03558867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558867.